CASTLE BIOSCIENCES, INC. Total Liabilities
CASTLE BIOSCIENCES, INC. (CSTL) had Total Liabilities of $91.15 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-30
- 2026-06-30: Liabilities $91.15M.
- 2026-03-31: Liabilities $86.39M.
- 2025-12-31: Liabilities $107.68M.
- 2025-09-30: Liabilities $95.74M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $91.15M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $86.39M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $107.68M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $95.74M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $89.35M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $61.41M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $75.40M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $73.51M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $63.42M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $56.05M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $62.07M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $50.24M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $46.63M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $41.74M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $48.18M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $46.38M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $36.72M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $47.09M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $50.83M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $21.98M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $19.62M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $18.75M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $23.64M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $43.84M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $43.92M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $32.32M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $34.63M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $30.86M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $36.94M 10-Q · filed 2019-09-03 | |
| 2018-12-31 | $32.48M 10-K · filed 2020-03-10 | $32.47M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |